Summary
Numerous amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation. These radioprotective agents can be classified into two broad groups, depending upon the presence or absence of a free or potentially free sulfhydryl group. The sulfhydryl-containing compounds have been studied extensively and are thought to exert their radioprotective effects by several mechanisms, including free radical scavenging and hydrogen atom donation. Several non-sulfhydryl-containing amino acids are also being investigated for their radioprotective effects. These agents are less well known than the familiar sulfhydryl compounds, but possess very interesting protective qualities. In short, the study of amino acids and their derivatives as radioprotective agents continues to contribute to an understanding of processes involved in radiation toxicity and to offer new compounds with potential application to situations of human exposure.
Similar content being viewed by others
References
Aarkrog A (1990) Environmental radiation and radioactive releases. Int J Radiat Biol 57: 619–631
Abe M, Takahashi M, Takeuchi K, Fukuda M (1968) Studies on the significance of taurine in radiation injury. Radiat Res 33: 563–573
Allalunis-Turner MJ, Walden TL, Sawich C (1989) Induction of marrow hypoxia by radioprotective agents. Radiat Res 118: 581–586
Allalunis-Turner MJ (1990) Reduced bone marrow pO2 following treatment with radioprotective drugs. Radiat Res 122: 262–267
Alper T, Howard-Flanders P (1956) Role of oxygen in modifying the radiosensitivity ofE. coli B. Nature 178: 978–979
Antoku S (1975) Chemical protection of cultured mammalian cells against fast neutrons. Int J Radiat Biol 27: 287–292
Ayene SI, Kale RK, Srivastava PN (1988) Radioprotective effects of 2-mercaptopropionyl glycine on radiation-induced lipid peroxidation and enzyme release in erythrocytes. Int J Radiat Biol 53: 629–639
Ayene SI, Srivastava PN (1985) Radioprotective effect of 2-mercaptopropionyl glycine on radiation-induced microsomal lipid peroxidation. Int J Radiat Biol 48: 197–205
Bacq ZM (1965) Chemical protection against ionizing radiation. Charles C Thomas, Springfield, Illinois
Bacq ZM, Alexander P (1964) Importance for radio-protection of the reaction of cells to sulphydryl and disulphide compounds. Nature 203: 162–164
Bacq ZM, Herve A, Lecomte J, Fischer P, Blavier J, Dechamps G, Le Bihan H, Rayet P (1951) Protection contre le rayonnement X par la ß-mercaptoéthylamine. Arch Internat Physiol 59: 442–447
Baker MA, Hagner BA (1990) Diamide induced shift in protein and glutathione thiol: disulfide status delays DNA rejoining after X-irradiation of human cancer cells. Biochim Biophys Acta 1037: 39–47
Barendsen GW, Walter HMD (1964) Effects of different ionizing radiations on human cells in tissue culture. IV. Modification of radiation damage. Radiat Res 21: 314–329
Barron ESG, Dickman S, Muntz JA, Singer TP (1949) Studies on the mechanism of action of ionizing radiations. I. Inhibition of enzymes by X-rays. J Gen Physiol 32: 537–552
Baskerville A, Hambleton P, Bengough JE (1980) Pathologic features of glutaminase toxicity. Br J Exp Pathol 61: 132–136
Basu SK, Chandra K, Chuttani K (1987) Radioprotection of peripheral blood cells with a combination of hydroxytryptophan and a thiol compound in mice. Acta Oncologica 26: 229–232
Bird RP (1980) Cysteamine as a protective agent with high-LET radiations. Radiat Res 82: 290–296
Bisht KS, Uma Devi P, Jagetia GC, Kamath G (1990) Drug combination against single drug treatment in radiation protection of the bone marrow CFU. Strahlenther Onkol 166: 545–548
Bogo V (1988) Behavioral radioprotection. Pharmacol Ther 39: 73–78
Broerse JJ, Dennis JA (1990) Dosimetric aspects of exposure of the population to ionizing radiation. Int J Radiat Biol 57: 633–645.
Brown DQ, Graham WJ, MacKenzie LJ, Pittock JW, Shaw LM (1988) Can WR-2721 be improved upon? Pharmacol Ther 39: 157–168.
Buc-Calderon P, Defresne MP, Barvais C, Roberfroid M (1989a)N-Acyl dehydroalanines protect from radiation toxicity and inhibit radiation carcinogenesis in mice. Carcinogenesis 10: 1641–1644
Buc-Calderon P, Praet M, Ruysschaert JM, Roberfroid M (1987) Free radical modulation byN-substituted dehydroalanines, a new way to improve therapeutic activity of anticancer drugs. Cancer Treat Rev 14: 379–382
Buc-Calderon P, Praet M, Ruysschaert JM, Roberfroid M (1989b) Increasing therapeutic effect and reducing toxicity of doxorubicin byN-acyl dehydroalanines. Eur J Cancer Clin Oncol 25: 679–685
Buc-Calderon P, Praet M, Ruysschaert JM, Roberfroid M (1990) Reduction of toxicity and increase of antitumor effect of adriamycin byN-acyl dehydroalanines, a new family of free radical scavengers. In: Emerit I (ed) Antioxidants in therapy and preventive medicine. Plenum Press, New York, pp 339–334
Buc-Calderon P, Roberfroid M (1988) Inhibition of O −2 - and HO.-mediated processes by a new class of free radical scavengers: TheN-acyl dehydroalanines. Free Radic Res Comm 5: 159–168
Buc-Calderon P, Roberfroid M (1989) Inhibition of rat liver microsomal lipid peroxidation byN-acyldehydroalanines: Anin vitro comparative study. Arch Biochem Biophys 273: 339–346
Bump EA, Brown JM (1990) Role of glutathione in the radiation response of mammalian cellsin vitro andin vivo. Pharmacol 47: 117–136
Cerutti PA, Nygaard OF, Simic MF (eds) (1988) Anticarcinogenesis and radiation protection. Plenum Press, New York
Clarke RH, Southwood TRE (1989) Risks from ionizing radiation. Nature 338: 197–198
Copeland ES (1978) Mechanisms of radioprotection — a review. Photochem Photobiol 28: 839–844
Dahl TA, Midden WR, Hartman PE (1988) Some prevalent biomolecules as defenses against singlet oxygen damage. Photochem Photobiol 47: 357–362
Demonchaux P, Laayoun A, Demeunynck M, Lhomme J (1989) Synthesis of N-acridinyl and N-quinolinyl derivatives of radioprotective amino-thiols. Tetrahedron 45: 6455–6466
Den Boer PJ, van Loon AAWM, Mackenbach P, van der Schans GP, Grootegoed JA (1990) Effect of glutathione depletion of the cytotoxicity of xenobiotics and induction of single-strand DNA breaks by ionizing radiation in isolated hamster round spermatids. J Reprod Fertil 88: 259–269
Denekamp J, Rojas A, Stevens G (1988) Redox competition and radiosensitivity: Implications for testing radioprotective compounds. Pharmacol Ther 39: 59–66
Dillon J, Kennedy JC, Pottier RH, Roberts JE (1988)In vitro andin vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913. Photochem Photobiol 48: 235–238
Djurhuus R, Svardal AM, Ueland PM (1990) Cysteamine increases homocysteine export and glutathione content by independent mechanisms in C3H/10T1/2 cells. Mol Pharmacol 38: 327–332
Dupin AM, Boldryev AA, Arkhipenko YV, Kagan VE (1984) Protection of Ca++ transport by carnosine against disturbances induced by lipid peroxidation. Bull Exp Biol Med 98: 1071–1073
Durand DE, Olive PL (1989) Radiosensitisation and radioprotection by BSO and WR-2721: The role of oxygenation. Br J Cancer 60: 517–522
Feuer L, Benkó G (1981) Effect of glutaurine and its derivatives and their combinations with radiation protective substances upon irradiated mice. Acta Radiol Oncol 20: 319–324
Feuer L, Kovacs P, Csaba G (1979) The effect of litoralon (gamma-L-glutamyl-taurine) on the lysosomal activity of mesenchymal cells and macrophages. Comp Biochem Physiol 64: 299–303
Feuer L, Kovacs P, Nagy Z, Török O, Csaba G (1980) Complex morphological study of the effect of glutaurine in mast cells. Acta Morphol Acad Sci Hung 28: 21–27
Feuer L, Ormai S (1978) Radioprotective effect of a protein free parathyroid extract. Experientia 34: 3–7
Feuer L, Török O, Csaba G (1978) Effect of glutaurine, a newly discovered parathyroid hormone, on rat thymus cultures. Acta Morphol Acad Sci Hung 26: 75–78
Floersheim GL, Bieri A (1990) Further studies on selective radioprotection by organic zinc salts and synergism of zinc aspartate with WR 2721. Br J Radiol 63: 468–475
Floersheim GL, Chiodetti N, Bieri A (1988) Differential radioprotection of bone marrow and tumour cells by zinc aspartate. Br J Radiol 61: 501–508
Floersheim GL, Floersheim P (1986) Protection against ionising radiation and synergism with thiols by zinc aspartate. Br J Radiol 59: 597–602
Foye WO (1969) Radiation-protective agents in mammals. J Pharm Sci 58: 283–300
Foye WO (1973) Mechanisms of radiation protection by the aminothiols. Int J Sulfur Chem 8: 161–171
Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JD (1990) Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Br Med J 300: 423–429
Geraci JP, Jackson KL, Mariano MS (1988) Protection against the physiological derangements associated with acute intestinal radiation injury. Pharmacol Ther 39: 45–57
Ghose A, Ganguly SK, Kaur J (1983) Protection with combinations of hydroxytryptophan and some thiol compounds against whole-body gamma irradiation. Int J Radiat Biol 44: 175–181
Glover D, Fox KR, Weiler C, Kligerman MM, Turrisi A, Glick JH (1988) Clinical trials of WR-2721 prior to alkylating chemotherapy and radiotherapy. Pharmacol Ther 39: 3–7
Glover D, Glick JH, Weller C, Fox K, Turrisi A, Kligerman MM (1986) Phase I/II trials of WR-2721 andcis-platinum. Int J Radiat Oncol Biol Phys 14: 1119–1122
Goffman TE, Raubitschek A, Mitchell JB, Glatstein E (1990) The emerging biology of modern radiation oncology. Cancer Res 50: 7735–7744
Grdina DJ, Nagy B, Sigdestad CP (1988) Radioprotectors in treatment therapy to reduce risk in secondary tumor induction. Pharmacol Ther 39: 21–25
Grunbaum ZA, Kroll K, Greene JL, Rasey JS, Krohn KA (1990) Synthesis and radiobiological applications of[35S]L-homocysteine thiolactone. Nucl Med Biol 17: 473–478
Halliwell B, Gutteridge JMC (1986) Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch Biochem Biophys 246: 501–514
Harris JW (1983) Cellular thiols in radiation and drug response: Use of specific reagents. In: Nygaard OF, Simic MG (eds) Radioprotectors and anticarcinogens. Academic Press, New York, pp 255–274
Hartman PE, Hartman Z, Citardi MJ (1988) Ergothioneine, histidine, and two naturally occurring histidine dipeptides as radioprotectors against gamma-irradiation inactivation of bacteriophages T4 and P22. Radiat Res 114: 319–330
Held KD, Harrop HA, Michael BD (1984) Effects of oxygen and sulphydryl-containing compounds on irradiated transforming DNA. II. Glutathione, cysteine and cysteamine. Int J Radiat Biol 45: 615–626
Hopewell JW (1990) The skin: Its structure and response to ionizing radiation. Int J Radiat Biol 57: 751–773
Issels RD, Nagele A (1989) Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status byS-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells. Cancer Res 49: 2082–2086
Kaluszyner A, Czerniak P, Bergmann ED (1961) Thiazolidines and aminoalkylthiosulfuric acids as protecting agents against ionizing radiation. Radiat Res 14: 23–28
Kay RE, Early JC, Entenman C (1957) Increased urinary excretion of taurine and urea by rats after X-irradiation. Radiation Res 6: 98–109
Kim J-A, Baker DG, Hahn SS, Goodchild NT, Constable WC (1983) Topical use of N-acetylcysteine for reduction of skin reaction to radiation therapy. Sem Oncol 10: 86–89
Kinsella TJ, Dobson PP, Russo A, Mitchell JB, Fornace AJ (1986) Modulation of X ray DNA damage by SR-2508 ± buthionine sulfoximine. Int J Radiat Oncol Biol Phys 12: 1127–1130
Klayman DL, Copeland ES (1975) The design of antiradiation agents. In: Ariëns EJ (ed) Drug design, vol 6. Academic Press, New York, pp 81–142
Klimberg VS, Salloum RM, Kasper M, Plumley DA, Dolson DJ, Hautamaki RD, Mendenhall WR, Bova FC, Bland KI, Copeland EM, Souba WW (1990a) Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg 125: 1040–1045
Klimberg VS, Souba WW, Dolson DJ, Salloum RM, Hautamaki RD, Plumley DA, Mendenhall WM, Bova FJ, Khan SR, Hackett RL, Bland KI, Copeland EM (1990b) Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer 66: 62–68
Kohn KW, Grimek-Ewig RA (1973) Alkaline elution analysis, a new approach to the study of DNA single-strand interruptions in cells. Cancer Res 33: 1849–1853
Kramer RA, Soble M, Howes AE, Montoya VP (1989) The effect of glutathione (GSH) depletionin vivo by buthionine sulfoximine (BSO) on the radiosensitization of SR 2508. Int J Radiat Oncol Biol Phys 16: 1325–1329
Lafleur MVM, Woldhuis J, Loman H (1980) Effects of sulphydryl compounds on the radiation damage in biologically active DNA. Int J Radiat Biol 37: 493–498
Lamperti A, Ziskin MC, Bergey E, Gorlowski J, Sodicoff M (1990) Transdermal absorption of radioprotectors in the rat using permeation-enhancing vehicles. Radiat Res 124: 194–200
Landauer MR, Davis HD, Dominitz JA, Weiss JF (1987) Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice. Pharmacol Biochem Behav 27: 573–576
Landauer MR, Hirsch DD, Dominitz JA, Weiss JF (1988) Comparative behavioral toxicity of four sulfhydryl radioprotective compounds in mice: WR-2721, cysteamine, diethyldithiocarbamate, andN-acetylcysteine. Pharmacol Ther 39: 97–100
Langendorff H, Melching HJ, Streffer C (1961) Der Einfluss des 5-Hydroxytryptamin auf strahlenbedingte Veränderungen des Aminosäurestoffwechsels. Strahlentherapie 116: 1–14
Langendorff M, Koch R (1958) Untersuchungen über einen biologischen Strahlenschutz. XXIII. Mitteilung Homocysteinthiolacton als Strahlenschutz. Strahlentherapie 106: 451–457
Lespinasse F, Oiry J, Fatome M, Ardouin A, Imbach J, Malaise EP, Guichard M (1985) Radioprotection of EMT6 tumor by a new class of radioprotectors based on a pseudopeptide cysteamine combination. Int J Radiat Oncol Biol Phys 11: 1035–1038
Levitt SH (1989) Radiation carcinogenesis. In: Vaeth JM, Meyer JL (eds) Radiation tolerance of normal tissues. Karger, Basel, pp 408–416
Lohman PHM, Vos O, Van Sluis CA, Cohen JA (1970) Chemical protection against breaks induced in DNA of human and bacterial cells by x-irradiation. Biochim Biophys Acta 224: 339–352
Mahaney FX (1990) Agent designed for war now in doctors' armamentarium. J Natl Cancer Inst 82: 255–257
Maurizis JC, Godeneche D, Madelmont JC, Moreau MF, Oiry J, Imbach JL, Veyre A (1988) Metabolism of a new radioprotector;S-acetyl-N-glycyl cysteamine. I. Absorption, distribution and excretion of metabolites in mice bearing EMT6 tumours. Xenobiotica 18: 1119–1128
Maurizis JC, Madelmont JC, Godeneche D, Moreau MF, Oiry J, Imbach JL, Veyre A, Meyniel G (1989) Metabolism of a new radioprotector;S-acetyl-N-glycyl cysteamine. II. Main tissue metabolites in mice bearing EMT6 tumours. Xenobiotica 19: 833–842
McCarthy KF, Hale ML (1988) Measurement of the radiosensitivity of rat marrow by flow cytometry. Pharmacol Ther 39: 79–83
McCully KS, Vezeridis MP (1989) Histopathological effects of homocysteine thiolactone on epithelial and stromal tissues. Exp Mol Pathol 51: 159–170
Melville DB (1958) Ergothioneine. Vitam Horm 17: 155–204
Mori T, Watanabe M, Horikawa M, Nikaido P, Kimura H, Aoyama T, Sugahara T (1983) WR-2721, its derivatives and their radioprotective effects on mammalian cells in culture. Int J Radiat Biol 44: 41–53
Murray D, vanAnkeren SC, Milas L, Meyn RE (1988) Radioprotective action of aminothiols invitro and in vivo: Comparison between effects on DNA damage and cell survival. Pharmacol Ther 39: 151–153
Nagy B, Dale DJ, Grdina DJ (1986) Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by WR-1065. Cancer Res 46: 1132–1135
Nagy B, Grdina DJ (1986) Protective effects of WR-1065 against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells. Int J Radiat Oncol Biol Phys 12: 1475–1478
Oiry J, Pue JY, Imbach JL, Fatome M, Sentenac-Roumanou H, Lion C (1986) Synthesis and radioprotective activity of new cysteamine and cystamine derivatives. J Med Chem 29: 2217–2225
Painter RB (1979) The role of DNA damage and repair in cell killing induced by ionizing radiation. In: Meyn RE, Withers HR (eds) Radiation biology in cancer research. Raven Press, New York, pp 59–68
Patt HM, Tyree EB, Straube RL, Smith DE (1949) Cysteine protection against X irradiation. Science 110: 213–214
Patt HM (1953) Protective mechanisms in ionizing radiation injury. Physiol Rev 33: 35–76
Peak MJ, Peak JG (1989) Solar-ultraviolet-induced damage to DNA. Photodermatol 6: 1–15
Phillips TL (1988) Overview of symposium: Physiologic mechanisms in radioprotection. Pharmacol Ther 39: 403–404
Praet M, Buc-Calderon P, Pollakis G, Roberfroid M, Ruysschaert JM (1988) A new class of free radical scavengers reducing adriamycin mitochondrial toxicity. Biochem Pharmacol 37: 4617–4622
Radford IR (1985) The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation. Int J Radiat Biol 48: 45–54
Radford IR (1986) Effect of radiomodifying agents on the ratios of X-ray-induced lesions in cellular DNA: Use in lethal lesion determination. Int J Radiat Biol 49: 621–637
Raleigh, JA (1988) Radioprotection of membranes. Pharmacol Ther 39: 109–113
Rao DV, Narra VR, Howell RW, Sastry KSR (1990) Biological consequence of nuclear versus cytoplasmic decays of125I: Cysteamine as a radioprotector against Auger cascadesin vivo. Radiat Res 124: 188–193
Rasey JS, Spence A, Badger CC, Krohn KA, Vera D, Livesley JC (1988) Specific protection of different normal tissues. Pharmacol Ther 39: 33–43
Révész L, Malaise EP (1983) Significance of cellular glutathione in radioprotection and repair of radiation damage. In: Larsson A (ed) Functions of glutathione: biochemical, physiological, toxicological, and clinical aspects. Raven Press, New York, pp 163–173
Révész L, Modig H (1965) Cysteamine-induced increase of cellular glutathione-level: a new hypothesis of the radioprotective mechanism. Nature 207: 430–431
Roberts JC, Francetic DJ, Zera RT (1990) L-Cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity. Cancer Chemother Pharmacol 28: 166–170
Russo A, Mitchell JB, Finkelstein E, DeGraff WG, Spiro IJ, Gamson J (1985) The effects of cellular glutathione elevation on the oxygen enhancement ratio. Radiat Res 103: 232–239
Sastry KSR, Rao DV (1986) Biological damage caused by Auger cascades. Lancet i: 858–859
Schor NF, Siuda JF, Lomis TJ, Cheng B (1990) Structural studies on the inactivation of gamma-glutamylcysteine synthetase by the disulphide analogues of radioprotective cysteamine derivatives. Biochem J 267: 291–296
Shaw SM (1990) Radiation: Still glowing in medicine. Am J Pharm Ed 54: 175–178
Shore RE (1990) Occupational radiation studies: Status, problems, and prospects. Health Phys 59: 63–68
Sigdestad CP, Guilford W, Perrin J, Grdina DJ (1988) Cell cycle redistribution of cultured cells after treatment with chemical radiation protectors. Cell Tissue Kinet 21: 193–200
Sodicoff M, Lamperti, A, Ziskin MC (1990) Transdermal absorption of radioprotectors using permeation-enhancing vehicles. Radiat Res 121: 212–219
Soupart P (1962) Free amino acids of blood and urine in the human. In: Holden T (ed) Amino acid pools. Elsevier, New York, pp 220–262
Srinivasan MN, Sarin RC, Basu SK (1989) Protection to testicular activity by a combination of 5-hydroxy L-tryptophan with a thiol compound in whole body gamma irradiated rats. Indian J Exp Biol 27: 640–643
Sutherland RM (ed) (1982) Conference on chemical modifiers: Radiation and cytotoxic drugs. Int J Radiat Oncol Biol Phys 8: 323–809
Sweeney TR (1979) A survey of compounds from the antiradiation drug development program of the U.S. Army Medical Research and Development Command. Walter Reed Army Institute of Research, Washington, DC
Tamba M (1989) Role of thiols in radioprotection: Radiation chemical aspects. Z Naturforsch 44c: 857–862
Terol A, Fernandez J-P, Robbe Y, Chapat J-P, Granger R, Fatome M, Andrieu L, Sentenac-Roumanou H (1978a) Recherche d'agents radioprotecteurs dérivés de la phényl-2 thiazolidine. Eur J Med Chem 13: 149–151
Terol A, Fernandez J-P, Robbe Y, Chapat J-P, Granger R, Sentenac-Roumanou H (1978b) Activité radioprotectrice et cinétique d'hydrolyse de phényl-2 thiazolidines. Eur J Med Chem 13: 153–154
Uma Devi P, Prasanna PGS (1990) Radioprotective effect of combinations of WR-2721 and mercaptopropionylglycine on mouse bone marrow chromosomes. Radiat Res 124: 165–170
vanAnkeren SC, Milas L, Murray D (1989) Protection of cultured Chinese hamster ovary cells by the aminothiol WR-255591 from the lethal and DNA-damaging effects of fast neutrons. Int J Radiat Oncol Biol Phys 16: 1205–1208
van der Schans GP, Groenendijk RH, Lohman PH (1988) Sensitive detection of single-strand breaks in DNA afterin vivo exposure to ionizing radiation to evaluate the effects of protecting agents. Pharmacol Ther 39: 147–148
Vaughan ATM, Grdina DJ, Meechan PJ, Milner AE, Gordon DJ (1989) Conformational changes in chromatin structure induced by the radioprotective aminothiol, WR 1065. Br J Cancer 60: 893–896
Verhey LJ, Sedlacek R (1983) Determination of the radioprotective effects of topical applications of MEA, WR-2721, andN-acetylcysteine on murine skin. Radiat Res 93: 175–183
Viehe HG, Janousek Z, Merenyi R, Stella L (1985) The capto-dative effect. Acc Chem Res 18: 148–154
Virsik RP, Harder D (1982) Effect of L-cysteine on the dose-effect relationship for chromosome aberrations in irradiation human lymphocytes. Int J Radiat Biol 42: 211–214
Vos O, Roos-Verhey WSD (1988) Radioprotection by glutathione esters and cysteamine in normal and glutathione-depleted mammalian cells. Int J Radiat Biol 53: 273–281
Walker RI (1988a) Acute radiation injuries. Pharmacol Ther 39: 9–12
Walker RI (1988b) Requirements of radioprotectors for military and emergency needs. Pharmacol Ther 39: 13–20
Walsh D (1897) Traumatism from Roentgen ray exposure. Br Med J 2: 272–273
Ward JF (1988) DNA damage produced by ionizing radiation in mammalian cells: Identities, mechanisms of formation and repairability. Prog Nucl Acids Mol Biol 35: 95–125
Ward WF, Molteni A, Ts'ao C-H, Solliday NH (1984) Radiation injury in rat lung. IV. Modification by D-penicillamine. Radiat Res 98: 397–406
Ward WF, Shih-Hoellwarth A, Johnson PM (1980) Survival of penicillamine-treated mice following whole-body irradiation. Radiat Res 81: 131–137
Ward WF, Shih-Hoellwarth A, Tuttle RD (1983) Collagen accumulation in irradiated rat lung: Modification by D-penicillamine. Radiol 146: 533–537
Wardman P (1990) Thiol reactivity towards drugs and radicals: Some implications in the radiotherapy and chemotherapy of cancer. In: Chatgilialoglu C, Asmus K-D (eds) Sulfurcentered reactive intermediates in chemistry and biology. Plenum Press, New York, pp 415–427
Watanabe H, Kamikawa M, Nakagawa Y, Takahashi T, Ito A (1988) The effects of ranitidine and cysteamine on intestinal metaplasia induced by X-irradiation in rats. Acta Pathol Jpn 38: 1285–1296
Weiss JF, Simic MG (eds) (1988) Perspectives in radioprotection. Pharmacol Ther 39: 1–407
Wellner VP, Anderson ME, Puri RV, Jensen GL, Meister A (1984) Radioprotection by glutathione ester: Transport of glutathione ester into human lymphoid cells and fibroblasts. Proc Natl Acad Sci USA 81: 4732–4735
Windmeuller HG (1982) Glutamine utilization by the small intestine. Adv Enzymol 53: 202–231
Yuhas JM (1970) Biological factors affecting the radioprotective efficiency of S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR 2721). LD50(30) doses. Radiat Res 44: 621–628
Yuhas JM, Culo F (1980) Selective inhibition of the nephrotoxicity ofcis-platinum without altering its antitumor effectiveness. Cancer Treat Rep 64: 57–64
Yuhas JM, Spellman JM, Culo F (1980) The role of WR-2721 in radiotherapy and/or chemotherapy. In: Brady LW (ed) Radiation sensitizers: Their use in the clinical management of cancer. Masson, New York, pp 303–308
Yuhas JM, Storer JB (1969) Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst 42: 331–335
Ziegler DM, Poulsen LL, Richerson RB (1983) Oxidative metabolism of sulfur-containing radioprotective agents. In: Nygaard OF, Simic MG (eds) Radioprotectors and anticarcinogens. Academic Press, New York, pp 191–202
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, J.C. Amino acids and their derivatives as radioprotective agents. Amino Acids 3, 25–52 (1992). https://doi.org/10.1007/BF00806007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00806007